High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer

High Numbers of CD163+ Tumor-Associated Macrophages Predict Poor Prognosis in HER2+ Breast Cancer

Tumor-associated macrophages (TAMs) are associated with a poor outcome in breast cancer (BC), but their prognostic value in different BC subtypes has remained somewhat unclear. Here, we investigated the prognostic value of M2-like TAMs (CD163+) and all TAMs (CD68+) in a patient cohort of 278 non-met...

Full description

Bibliographic Details
Main Authors: Minna M. Jääskeläinen, Ritva Tumelius, Kirsi Hämäläinen, Kirsi Rilla, Sanna Oikari, Aino Rönkä, Tuomas Selander, Arto Mannermaa, Satu Tiainen, Päivi Auvinen
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Cancers
Subjects:
tumor-associated macrophage
HER2
CD163
CD68
breast cancer
trastuzumab
Online Access:https://www.mdpi.com/2072-6694/16/3/634

Internet

https://www.mdpi.com/2072-6694/16/3/634

Similar Items